H.R. 5488: Special Diabetes Program for Indians Reauthorization Act of 2025

HR 5488 is a straightforward reauthorization bill for the Special Diabetes Program for Indians. It amends section 330C(c)(2) of the Public Health Service Act, codified at 42 U.S.C. 254c-3(c)(2), to continue funding instead of letting the program face uncertainty after the current authorization period ends.

The core policy choice is simple: authorize $160,000,000 for each fiscal year from 2026 through 2030. That means a total of $800,000,000 over five fiscal years if Congress provides the full authorized amount each year. The bill also says the money remains available until expended, which gives the program more flexibility than a one-year use-it-or-lose-it funding window.

Because the bill focuses only on extending funding, it does not create new eligibility rules, new penalties, or new age brackets. Its main effect is continuity. For tribal communities and health systems that rely on the Special Diabetes Program for Indians, predictable funding for fiscal years 2026, 2027, 2028, 2029, and 2030 can support longer-term planning, staffing, and diabetes prevention and treatment efforts.

The bill sits in the Native Americans and public health space, and its impact is practical rather than flashy. Reauthorization at $160,000,000 per year signals that Congress wants the Special Diabetes Program for Indians to keep operating at a substantial federal funding level, with funds available until spent rather than expiring at the end of each fiscal year.